Stock Events

Stock Events

Apellis Pharmaceuticals (APLS) Q3 2023 Earnings

1NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-1.57

-1.33

-1.09

-0.85

Details

Expected EPS

-0.85

Actual EPS

-1.17

Surprise EPS

-0.32

Surprise Percent

+37.65%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -1.17 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.